Pages that link to "Q37029735"

The following pages link to A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease (Q37029735):

Displaying 24 items.

• The Natural Course of Non-Alcoholic Fatty Liver Disease (Q26746947) (← links)
• Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV (Q28079826) (← links)
• Hepatic estrogen receptor α is critical for regulation of gluconeogenesis and lipid metabolism in males (Q33687175) (← links)
• Non-alcoholic fatty liver disease: An expanded review (Q33789868) (← links)
• NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. (Q33844463) (← links)
• Hormone receptor expression in human fascial tissue. (Q37467547) (← links)
• Extra-gonadal sites of estrogen biosynthesis and function (Q37581076) (← links)
• Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosis (Q38843287) (← links)
• An estrogen receptor β-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors (Q39018492) (← links)
• Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients. (Q40074576) (← links)
• Reproductive Aging and Hepatic Fibrosis Progression in HIV/Hepatitis C Virus Co-Infected Women. (Q41919094) (← links)
• Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195/miR4668 maturation (Q49471259) (← links)
• CHI3L1 promotes tumor progression by activating TGF-β signaling pathway in hepatocellular carcinoma (Q57292487) (← links)
• Alcohol and hepatocellular carcinoma (Q64244143) (← links)
• Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview (Q64249695) (← links)
• Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation (Q90020289) (← links)
• Beneficial and Deleterious Effects of Female Sex Hormones, Oral Contraceptives, and Phytoestrogens by Immunomodulation on the Liver (Q90224956) (← links)
• Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (Q90750222) (← links)
• Attributable Fractions of NAFLD for Mortality in the United States: Results From NHANES III With 27 Years of Follow-up (Q91304675) (← links)
• Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps (Q92697803) (← links)
• NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management (Q92853271) (← links)
• Expression of mitochondrial membrane-linked SAB determines severity of sex-dependent acute liver injury (Q93122181) (← links)
• Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Nonobese Postmenopausal Women: A Cross-sectional Study (Q96640781) (← links)
• Reproductive Health and Nonalcoholic Fatty Liver Disease in Women: Considerations Across the Reproductive Lifespan (Q96951670) (← links)